| Page 1494 | Kisaco Research
 

Alex Grose

Chief Commercial Officer
Kisaco Research

Alex Grose

Chief Commercial Officer
Kisaco Research

Alex Grose

Chief Commercial Officer
Kisaco Research
 
Transcription Factor Drug Development 2021
6-8 Jul 2021
VIRTUAL SUMMIT | EDT Timezone
With an increasing number of projects entering the pipeline both clinically and pre-clinically aimed at targeting "undruggable" transcription factors, the industry is ready to develop further insight into the commercialization of TF-based therapeutics within oncology and other disease settings. Harnessing functional biology and translational research to evaluate which strategies - including PPI inhibitors, TRAFTACs and RNA modulators - are most effective in targeting these elusive proteins is crucial to stay ahead of the curve!The Transcription Factor Drug Development Congress is one of a kind!For the second year running, we will bring together leading industry players within large pharma and biotech, along with expert academics in transcriptomics, epigenetics, and oncology drug discovery. With a year of virtual events under our belt, our streamlined platform will provide an open forum to facilitate the sharing of in vitro and in vivo data, as well as build a deeper understanding of transcriptional machinery to make the ‘undruggable’ druggable. Use 1-2-1 meetings, interactive roundtables and discussions as well as networking roulette to hear strategies that will help you overcome the structural biology, pharmacology, and chemical obstacles in the design and development of TF-based therapeutics. Here’s a sneak peek at our 2021 offering:Understand how chromatin remodelling machinery is involved in DNA binding of the transcriptome and use this to inform targeted epigenetic therapiesAnalyse hot-off-the-press approaches to targeting myc, STAT, p53 and more including TRAFTACs, protein degraders, CPPs and PPI inhibitorsLearn how to build effective collaborations between academic labs, biotech and pharma and get insight into transcriptome and epigenetic focused tool development
 

Mikayla Johnson

Vice President Global Solutions
Carrot Fertility

Mikayla Johnson

Vice President Global Solutions
Carrot Fertility

Mikayla Johnson

Vice President Global Solutions
Carrot Fertility
 

Marissa Nelson LMFT CST CSE

Founder & CEO
IntimacyIVF

Marissa Nelson LMFT CST CSE

Founder & CEO
IntimacyIVF

Marissa Nelson LMFT CST CSE

Founder & CEO
IntimacyIVF
 

Ronald F. Feinberg, M.D., PhD

Founding Partner, Medical Director of IVF Programs
RADFertility

Ronald F. Feinberg, M.D., PhD

Founding Partner, Medical Director of IVF Programs
RADFertility

Ronald F. Feinberg, M.D., PhD

Founding Partner, Medical Director of IVF Programs
RADFertility
 

Benoit Felten

Chief Research Officer
Diffraction Analysis

CEO and founder of Diffraction Analysis, Benoît Felten is a recognized expert on issues related to Next-Generation-Access. Felten’s expertise stems from an understanding of the business model issues of fixed network rejuvenation and from there expands into all aspects impacting the business model: technology choices, service opportunities, go to market strategies, regulation, etc. He also analyses public policies aiming at promoting the deployment of fiber rich networks.

Benoit Felten

Chief Research Officer
Diffraction Analysis

Benoit Felten

Chief Research Officer
Diffraction Analysis

CEO and founder of Diffraction Analysis, Benoît Felten is a recognized expert on issues related to Next-Generation-Access. Felten’s expertise stems from an understanding of the business model issues of fixed network rejuvenation and from there expands into all aspects impacting the business model: technology choices, service opportunities, go to market strategies, regulation, etc. He also analyses public policies aiming at promoting the deployment of fiber rich networks.

With 5G approaching, his expertise develops outwards as the lines between fixed and wireline broadband blur, architecturally and from a policy perspective. His recent work has focused on addressing market stability issues and risks of increased digital divide that may result from a haphazard development of 5G.

Before starting Diffraction Analysis, Felten was a Director of Access Network Research at Yankee Group where he led the company’s research efforts in the NGA field. Prior to that, Felten was a Telecoms Consultant for 8 years, and even further back worked at deploying and selling fiber access to businesses in Belgacom's French subsidiary.

Felten lives between Hong Kong in Paris. He complements his day job by blogging about the economic and social impacts of next generation access on www.diffractionanalysis.com and tweets under the handle of @fiberguy.

 

Mark Maybury

Chief Technology Officer
Stanley Black & Decker

MARK MAYBURY is Stanley Black & Decker’s first Chief Technology Officer. In this position, Mark manages a team across the company's businesses and functions and advises on technological threats and opportunities, as well as provides access to all elements of the global technology ecosystem.

Mark Maybury

Chief Technology Officer
Stanley Black & Decker

Mark Maybury

Chief Technology Officer
Stanley Black & Decker

MARK MAYBURY is Stanley Black & Decker’s first Chief Technology Officer. In this position, Mark manages a team across the company's businesses and functions and advises on technological threats and opportunities, as well as provides access to all elements of the global technology ecosystem.

Prior to joining Stanley Black & Decker, Mark spent 27 years at The MITRE Corporation, where he held a variety of strategic technology roles. Most recently he served as Vice President of Intelligence Portfolios and prior to that was MITRE's Vice President and Chief Security Officer and Director of the National Cybersecurity Federally Funded Research and Development Center (FFRDC). Before joining MITRE, Mark served as a U.S. Air Force officer. He later returned to the Air Force as Chief Scientist from 2010 to 2013 where he advised the Chief of Staff and Secretary of the Air Force on a wide range of scientific and technical issues.

He is currently a board member on the Defense Science Board, Mark Twain House and Museum Board and the Connecticut Science Center Board and previously served on multiple years of service on the Air Force Scientific Advisory Board and the Homeland Security Science and Technology Advisory committee. He is a fellow in both the IEEE and the Association for the Advancement of Artificial Intelligence.

Mark earned a bachelor's degree in mathematics from College of the Holy Cross (Fenwick Scholar, valedictorian), a master's degree in computer speech and language processing from Cambridge University, England (Rotary Scholar), a Master of Business Administration from Rensselaer Polytechnic Institute, and a doctoral degree in artificial intelligence also from Cambridge University.

 

Aart de Geus

Chairman & Co-CEO
Synopsys

Since co-founding Synopsys in 1986, Aart has expanded Synopsys from a start-up synthesis company to a global high-tech leader. He has long been considered one of the world's leading experts on logic synthesis and simulation, and frequently keynotes major conferences in electronics and design automation. Dr. de Geus has been widely recognized for his technical, business, and community achievements with multiple awards including Electronic Business Magazine's "CEO of the Year," the IEEE Robert N.

Aart de Geus

Chairman & Co-CEO
Synopsys

Aart de Geus

Chairman & Co-CEO
Synopsys

Since co-founding Synopsys in 1986, Aart has expanded Synopsys from a start-up synthesis company to a global high-tech leader. He has long been considered one of the world's leading experts on logic synthesis and simulation, and frequently keynotes major conferences in electronics and design automation. Dr. de Geus has been widely recognized for his technical, business, and community achievements with multiple awards including Electronic Business Magazine's "CEO of the Year," the IEEE Robert N. Noyce Medal, the GSA Morris Chang Exemplary Leadership Award, the Silicon Valley Engineering Council Hall of Fame Award, and the SVLG Lifetime Achievement Award. He serves on the Boards of the Silicon Valley Leadership Group, Applied Materials, the Global Semiconductor Alliance, and the Electronic System Design Alliance.

 

Dr Elizabeth Mueller

Head of Female Pelvic Medicine
Loyola University Medical Center, Chicago

Dr Elizabeth Mueller

Head of Female Pelvic Medicine
Loyola University Medical Center, Chicago

Dr Elizabeth Mueller

Head of Female Pelvic Medicine
Loyola University Medical Center, Chicago
 

Missy Lavender

CEO
Renalis Health

Missy Lavender

CEO
Renalis Health

Missy Lavender

CEO
Renalis Health